IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2025 Holdings

Filed 2025-08-14 | 7 holdings | $154.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Innoviva Inc(INVA)COM45781M101$56.6M2,816,02236.6%
Neurocrine Biosciences Inc(NBIX)COM64125C109$38.1M303,15124.7%
Amarin Corp PLC(EH3)SPONSORED ADR023111404$20.2M1,242,52713.1%
Cytokinetics Inc(CYTK)COM NEW23282W605$19.4M588,35712.6%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$11.4M15,919,4357.4%
Lantheus Hldgs Inc(LNTH)COM516544103$7.9M96,2515.1%
VOR Biopharma IncCOM929033108$823.0K508,0160.5%